Benzinga - by Lisa Levin, Benzinga Editor. U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording gains in today’s pre-market trading session.
- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) shares jumped 29.3% to $39.77 in pre-market trading after the company said events of retinal vasculitis in treatment with SYFOVRE were rare, with an estimated real-world rate of 0.01% per injection.
- iTeos Therapeutics, Inc. (NASDAQ: ITOS) climbed 23.6% to $14.52 in pre-market trading. ITeos Therapeutics recently reported a loss for the second quarter.
- Arcus Biosciences, Inc. (NYSE: RCUS) shares gained 22.1% to $22.97 in pre-market trading. Arcus Biosciences recently posted downbeat quarterly results.
- Hitek Global Inc. (NASDAQ: HKIT) shares rose 13.3% to $31.50 in pre-market trading after jumping 24% on Tuesday.
- AMTD Digital Inc. (NYSE: HKD) gained 12.1% to $7.14 in pre-market trading. AMTD Digital shares gained 27% on Tuesday after the company announced a $30 million share repurchase program.
- Manchester United plc (NASDAQ: MANU) shares rose 9.6% to $23.90 in pre-market trading.
- Arcos Dorados Holdings Inc. (NYSE: ARCO) climbed 8.9% to $10.87 in pre-market trading. Blink Charging entered into an agreement with Arcos Dorados Holdings to provide EV charging solutions to five restaurants in Puerto Rico.
- Urban Outfitters, Inc. (NASDAQ: URBN) gained 7.1% to $36.50 in pre-market trading as the company reported better-than-expected second-quarter earnings. Its total inventory decreased by 15.9% year-over-year as of July 31.
- VinFast Auto Ltd. (NASDAQ: VFS) gained 6.6% to $39.13 in pre-market trading. VinFast shares jumped 109% on Tuesday following a Reuters report suggesting SGI, which supplies magnets to VinFast, is investing $80 million in its new Vietnam factory with production starting in 2024.
- Toll Brothers, Inc. (NYSE: TOL) gained 3% to $78.18 in pre-market trading as the company reported upbeat results for its third quarter. The company expects to deliver between 2,650 and 2,750 units in the fourth quarter, up from 2,524 in the third quarter.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Don’t forget to check out our premarket coverage here
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.